Back to
RENAISSANCE TECHNOLOGIES LLC
ANTX12 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in AN2 THERAPEUTICS INC
Yes. Renaissance Technologies holds 129,700 shares of ANTX (AN2 Therapeutics), worth $627,748, as of its Q2 2026 13F filing. It reduced the position by 69,100 shares (-34.8%) from Q1 2026. Renaissance Technologies has held ANTX since Q2 2024, across 9 quarterly 13F filings.
Current Value
$627,748
Current Shares
129,700
Total Value Change
+$428,748
Total Shares Change
+104,000
Quarter-by-Quarter History
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.